4.4 Article

Effects of carbohydrate restriction and dietary cholesterol provided by eggs on clinical risk factors in metabolic syndrome

Journal

JOURNAL OF CLINICAL LIPIDOLOGY
Volume 7, Issue 5, Pages 463-471

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacl.2013.03.008

Keywords

Body composition; Carbohydrate restriction; Dietary cholesterol; Eggs; Inflammation; Metabolic syndrome

Funding

  1. Egg Nutrition Center

Ask authors/readers for more resources

BACKGROUND: There are a limited number of clinical interventions evaluating the effects of dietary cholesterol in individuals at elevated risk for type 2 diabetes and cardiovascular disease. OBJECTIVE: To investigate the effects of whole egg intake in adults with metabolic syndrome (MetS). METHODS: Men (n = 12) and women (n = 25) with MetS were instructed to follow a moderate carbohydrate-restricted diet (<30% energy) and randomly assigned to consume either three whole eggs (EGG, n = 20) or egg substitute (SUB, n = 17)/d for 12 weeks. Dietary intake, MetS parameters, and body composition were assessed at baseline and post-intervention. RESULTS: Total carbohydrate (P<.001) intake decreased in all participants over time. The EGG group consumed more dietary cholesterol (P<.001) and choline (P <.001) than the SUB group. MetS was reduced in both groups, with improvements noted in dyslipidemia and decreases in waist circumference (P<.01), weight (P<.001), and percent body fat (P<.001). Reductions in plasma tumor necrosis factor-alpha (P <.001) and serum amyloid A (P<.05) were seen in the EGG group only. Notably, increases in dietary cholesterol were associated with reductions in plasma tumor necrosis factor(r = -0.340, P =.04). Plasma C-reactive protein, adiponectin, interleukin-6 interleukin-10, and cell adhesion molecules were unaffected by the intervention. CONCLUSIONS: These results demonstrate that on a moderate carbohydrate background diet, accompanied by weight loss, the inclusion of whole eggs improves inflammation to a greater extent than yolk-free egg substitute in those with MetS. (C) 2013 National Lipid Association. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available